Correlation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial

Autor:	Olivier Tredan, V. Agrapart, Sylvie Chabaud, Mehdi Brahmi, P. A. Cassier, C. de la Fouchardiere, I.L. Ray-Coquard, L. Birnbaum, A D'argenio, Qing Wang, Valéry Attignon, Benoit You, O. Zelichov, D. Perol, Zohar Barbash, Y. Daitsh, Christian Baudet, Gabi Tarcic, J.-Y. Blay, G. Fournier Garin
Rok vydání:	2018
Předmět:	Oncology Functional assay medicine.medical_specialty business.industry Sorafenib treatment Hematology Tumor response Clinical trial Correlation Internal medicine Medicine Sensitivity (control systems) business
Zdroj:	Annals of Oncology. 29:vi15-vi16
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy318.025
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2aef7c6c8da9984a3f260f62198e0829 https://doi.org/10.1093/annonc/mdy318.025 Zobrazit plný text záznamu